The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.
Siragusa
Sergio
S
Thrombosis/Haemostasis and Haematology Unit, University Hospital of Palermo, Italy. sergio.siragusa@unipa.it
Malato
Alessandra
A
Cigna
Valeria
V
Anastasio
Raffaela
R
Coco
Lucio Lo
LL
Casuccio
Alessandra
A
Ciaccio
Marcello
M
D000368:Aged; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014803:Vitamin B Complex / Q000627:therapeutic use*
D006710:Homocysteine; D014803:Vitamin B Complex; D005492:Folic Acid